Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001790340-25-000020·Immuneering Corp
Schedule 13G ownership disclosure
Immuneering Corp
Class A common stock, par value $0.001 per share · CUSIP: 45254E107
Event date: 2024-12-31
- Filing-level shares
- 3,978,168.00
- Percent of class
- 12.8%
- BENJAMIN J. ZESKIND
Shares: 3,978,168.00 · Class: 12.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001790340-25-000020
- Form type
- SCHEDULE 13G/A
- Filer
- Immuneering Corp
- CIK
- CIK 1790340
- Filed
- Jan 17, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership